Improvement in disease severity and quality of life in patients with atopic dermatitis treated with dupilumab for up to 18 months: real-world data from the canadian cohort of the prose registry
ACTA DERMATO-VENEREOLOGICA(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要